{"name":"Pharmicell Co., Ltd.","slug":"pharmicell-co-ltd","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":4,"colorKey":"oncology","drugs":[{"name":"Cellgram-CKD","genericName":"Cellgram-CKD","slug":"cellgram-ckd","indication":"Other","status":"phase_1"},{"name":"Cellgram-LC","genericName":"Cellgram-LC","slug":"cellgram-lc","indication":"Graft-versus-host disease (GVHD)","status":"phase_3"},{"name":"Hearticellgram-AMI","genericName":"Hearticellgram-AMI","slug":"hearticellgram-ami","indication":"Acute myocardial infarction with reduced left ventricular ejection fraction","status":"phase_3"},{"name":"Livercellgram","genericName":"Livercellgram","slug":"livercellgram","indication":"Other","status":"phase_2"}]},{"name":"Oncology","slug":"oncology","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"immunology","drugs":[{"name":"Cellgram-ED","genericName":"Cellgram-ED","slug":"cellgram-ed","indication":"Metastatic solid tumors","status":"phase_2"}]}],"pipeline":[{"name":"Cellgram-CKD","genericName":"Cellgram-CKD","slug":"cellgram-ckd","phase":"phase_1","mechanism":"Cellgram-CKD is a cell-based therapy designed to promote kidney tissue regeneration and improve renal function in chronic kidney disease patients.","indications":[],"catalyst":""},{"name":"Cellgram-LC","genericName":"Cellgram-LC","slug":"cellgram-lc","phase":"phase_3","mechanism":"Cellgram-LC is an allogeneic mesenchymal stem cell therapy that modulates immune responses and promotes tissue repair through paracrine signaling.","indications":["Graft-versus-host disease (GVHD)","Inflammatory bowel disease"],"catalyst":""},{"name":"Cellgram-ED","genericName":"Cellgram-ED","slug":"cellgram-ed","phase":"phase_2","mechanism":"Cellgram-ED is a small molecule that targets the CD47/SIRPα axis to modulate the immune response.","indications":["Metastatic solid tumors","Relapsed or refractory multiple myeloma"],"catalyst":""},{"name":"Hearticellgram-AMI","genericName":"Hearticellgram-AMI","slug":"hearticellgram-ami","phase":"phase_3","mechanism":"Hearticellgram-AMI is an autologous bone marrow-derived cell therapy that promotes cardiac regeneration and repair following acute myocardial infarction.","indications":["Acute myocardial infarction with reduced left ventricular ejection fraction"],"catalyst":""},{"name":"Livercellgram","genericName":"Livercellgram","slug":"livercellgram","phase":"phase_2","mechanism":"Biologic","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiaEFVX3lxTE9SY1ViQ01sTG5MT0IweGU0Vm1KWDFoRjBMbjdZZUR5d2xROU45bk1TRXYxS1hLT1Q4cXdncW9NeWFoWHZTcHY5VzM5TEU2dGpXa1RILWNCdFZZLUtzZjJVRHZSaExZOTg5?oc=5","date":"2026-04-04","type":"pipeline","source":"Yahoo! Finance Canada","summary":"Oncology Pharma Inc. (ONPH) Analyst Insights, Price Targets & Recommendations - Yahoo! Finance Canada","headline":"Oncology Pharma Inc. (ONPH) Analyst Insights, Price Targets & Recommendations - Yahoo! Finance Canada","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikgFBVV95cUxPN3hqc0ZlUG9MWV96eUQ3RWlSdXNLMVJfTHlVYi0yZFNTb0tuYi1iTTYyVFJrZDNVM21FUVJfbXJ4OFBsNHN5cVJ3MTRoVHlwZHM3Sm1idG5lTzV5aWtFRkU1RUNXeEJWVm9YRnFYUmYzVUpnckFBeldiTmVtNU5ncGpLX3lXWUMzOTEyMHRGTXVBQQ?oc=5","date":"2024-03-25","type":"trial","source":"Yahoo Finance","summary":"Cirrhosis Clinical Trial Pipeline Insights Featuring 45+ Companies | DelveInsight - Yahoo Finance","headline":"Cirrhosis Clinical Trial Pipeline Insights Featuring 45+ Companies | DelveInsight","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi2gFBVV95cUxPR0thLTNsT2J2Y1BaQkhURl9SZ2syRzlEUGVGcm43blhfbnVhNGxmSmwtbmpqN1E1dUJrbWNEQjFhYVZmYTBlaUI1Mm41S3FzSnhmUXZNbWY0VExDaGZlVzlpbW5XVnJ4UnR4NjBpdmFzSl9mYk5RbnlOMGVuTGFpcDlYci1vSzRoc0JTQVdTbjU5eUM1OEtaTWNGZUI2eUlaUW0yZjd5RmZQVnJfWmlQYm82LUV4cGJBWFdPM1NTbEg4M2hlaDRGdEV4ajhrT0FMOVpKblJDZWt3dw?oc=5","date":"2024-03-14","type":"pipeline","source":"The Worldfolio","summary":"Pharmicell's bold vision for healthcare transformation - The Worldfolio","headline":"Pharmicell's bold vision for healthcare transformation","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilAFBVV95cUxQNl9DaTB2Q01KSXA1NmZjRm9pcGhtNjR3UnlwVTZCRXFxVngyWlRqRXhfLWNFZDJLNEpFSy16QVZzZ3QyVk5ISkp1ZGJ5MUxTa1M2V2ZfUVpEYkV3QUZIdnQzZWRpVDFsLVptRDZZb3JPa3FoQTlGckJ3aDAwcnlxR3RCR0RDaURvR0hGRlprdU0wOUlJ?oc=5","date":"2023-12-12","type":"pipeline","source":"BioSpace","summary":"CAR T-Cell Therapy Market Size, Share, Growth, Trends, Report By 2032 - BioSpace","headline":"CAR T-Cell Therapy Market Size, Share, Growth, Trends, Report By 2032","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi6wFBVV95cUxPOXduWVp5b19OWFd5R1BzMkZvcldONC0xVEc3NTh1aEhJLU5HV1Q0Ni0zZlVxUGFzemZoRzBWdmVPOUJ0eXVnZVdKeGtQVTlQMmJNdEwzaWptc2puZTg2dFM5Vkk1XzlUX3R6bjllTTRVeGhzcGlzVTdkNXk0amx3bS1HWUY1UHdWOFlCNnhqS2ZlLVVhRmdHQWhDV3VncVRDcUlpUnU5b204Q3BEazN3bXRBclJZdDByMjQxNDZCX3RIWG9UVWc3YlV6Uk9UWGUyeGUyUmhlbEV0ZjVfYlJmbGVYMDR5YXBFeXAw?oc=5","date":"2023-07-12","type":"pipeline","source":"PR Newswire","summary":"Liver Cirrhosis Market to Observe Impressive Growth at a CAGR of 6.3% by 2032, Predicts DelveInsight - PR Newswire","headline":"Liver Cirrhosis Market to Observe Impressive Growth at a CAGR of 6.3% by 2032, Predicts DelveInsight","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilwFBVV95cUxQZFVNZjlUZ0xsNWUyempLMTAtQnE2NWI5RUEzMXNMU3pyRDRzMFlEOGxzT2pJcWxQNktLLTRxYlhFUjhEOXRrc2VmREpodUx5VEI5VzJjRWVfc0I2Y0JUUUVZYWJOMU5Lc2FwTmxwdk9HZk1KeEFnNlJTNk9YMnc1NjRTRWtlUHpDUW1WalZMcWREN2hDaUk4?oc=5","date":"2023-05-17","type":"pipeline","source":"openPR.com","summary":"Ovarian Cancer Pipeline Assessment (2023 Updates) | In-depth - openPR.com","headline":"Ovarian Cancer Pipeline Assessment (2023 Updates) | In-depth","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiUkFVX3lxTFBVTVU4eWpJb3dtTzQ1TGxBZndINTRyR0FtRHRTNnN4bHJKZzZYM2MtNC0yNVF6Vm1mQktEcDZGc2R3ZklLaG1MMHRPM1NjZHhYRUE?oc=5","date":"2021-01-03","type":"pipeline","source":"sg.finance.yahoo.com","summary":"Oncology Pharma Inc. (ONPH) stock price, news, quote and history - sg.finance.yahoo.com","headline":"Oncology Pharma Inc. (ONPH) stock price, news, quote and history","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMicEFVX3lxTE5ZQzhDSUdqRjhEaFJNUWkxRWtCdl9rZ21BZXJoZjREUXZscUZ5ckhaWmFqX3BsdUdVOEhIcjYzaTI1Z1R5ZHE0VVVwdWpPNnRWMHUtUWNQeTNYWlAwSlAxV19INVRxdkhSZzF3UHBaaEQ?oc=5","date":"2019-03-31","type":"pipeline","source":"Straits Research","summary":"Regenerative Medicine Market Size, Share & Growth Graph by 2034 - Straits Research","headline":"Regenerative Medicine Market Size, Share & Growth Graph by 2034","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTE9BVUxHZzIxc1hPN2h5YjJkdnU3NmgyNUN0Z2NZQkNjOE9ueVdGV2MtWEtYeEN3UThOcm55REIzYUY1dHZscDFVenNSTXo1TXNpeTJhZFg4VEZqUkxuTDdV?oc=5","date":"2018-12-20","type":"regulatory","source":"Market.us","summary":"Stem Cell Therapy Market Demand, Trend Analysis | CAGR 25.3% - Market.us","headline":"Stem Cell Therapy Market Demand, Trend Analysis | CAGR 25.3%","sentiment":"neutral"}],"patents":[],"drugCount":5,"phaseCounts":{"phase_1":1,"phase_3":2,"phase_2":2},"enrichmentLevel":0,"visitCount":4,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}